NAVITOR VISION
Report
- Report Number
- 2135147-2024-05229
- Event Type
- Injury
- Date Received
- October 21, 2024
- Date of Event
- September 26, 2024
- Report Date
- January 17, 2025
- Manufacturer
- ABBOTT MEDICAL
- Product Code
- NPT
- UDI-DI
- 05415067045782
- PMA / PMN Number
- P190023
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
AN EVENT OF VALVE UNDEREXPANSION, CENTRAL REGURGITATION, PERIVALVULAR LEAK (PVL), INCOMPLETE COAPTATION, PATIENT DEVICE INTERACTION PROBLEM, HEART FAILURE, AND HOSPITALIZATION WAS REPORTED. A RETURNED DEVICE ASSESSMENT COULD NOT BE PERFORMED AS THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE DEVICE HISTORY RECORD WAS REVIEWED TO ENSURE THAT EACH MANUFACTURING AND INSPECTION OPERATION WAS PERFORMED, AND THE PRODUCT MET ALL SPECIFICATIONS. BASED ON THE AVAILABLE INFORMATION AND CINE REVIEW, THE CAUSE OF THE REPORTED VALVE UNDEREXPANSION, CENTRAL REGURGITATION, PVL, AND INCOMPLETE COAPTATION COULD NOT BE CONCLUSIVELY DETERMINED. THE REPORTED HOSPITALIZATION AND UNEXPECTED MEDICAL INTERVENTION WERE RESULTS OF CASE-SPECIFIC CIRCUMSTANCES. DURING THE PROCEDURE, A POST-BALLOON AORTIC VALVULOPLASTY (POST-BAV) WAS PERFORMED. FOLLOWING THE PROCEDURE, THE PATIENT WAS ADMITTED FOR HEART FAILURE AND TREATED WITH DIURETICS. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO LABELING DESIGN OR MANUFACTURING OF THE DEVICE.
INVESTIGATION IS NOT YET COMPLETE. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.
IT WAS REPORTED THAT ON (B)(6) 2024, A 25MM NAVITOR VISION TRANSCATHETER AORTIC VALVE (SERIAL: (B)(6)) WAS CHOSEN FOR IMPLANTATION UTILIZING A SMALL FLEXNAV DELIVERY SYSTEM (LOT: 9119719). PRE-DILATATION WAS PERFORMED WITH CAMEL 20 MM (GOODMAN CO., LTD.) BALLOON. SIGNIFICANT CALCIFICATION WAS OBSERVED IN THE STJ (SINOTUBLAR JUNCTION), BUT NO CALCIFICATION THAT WOULD CREATE A RISK FOR NUE WAS SEEN IN THE ANNULUS OR SOV (SINUS OF VALSALVA). DURING FIRST DEPLOYMENT ATTEMPT, NON-UNIFORM EXPANSION OCCURRED AND THE DEPTH WAS SHALLOW SO THE NAVITOR WAS RECAPTURED. SECOND ATTEMPT WAS STILL TOO SHALLOW. ON THE THIRD ATTEMPT, 80% ACHIEVED WITHOUT NON-UNIFORM EXPANSION AT DEPTH OF 5MM NON CORONARY CUSP, 3MM LEFT CORONARY CUSP. MILD PARAVALVULAR LEAK WAS PRESENT AND SLIGHT CENTRAL REGURGITATION. FULL DEPLOYMENT WAS PERFORMED. THERE WAS NO MIGRATION. AFTER GUIDEWIRE REMOVAL, MILD PVL WAS STILL OBSERVED ALONG WITH CENTRAL REGURGITATION. ON CT, THE VALVE WAS OBSERVED TO BE POORLY EXPANDED. POST BALLOON ANNULAR VALVULOPLASTY WAS PERFORMED WITH A Z-MED 22MM BALLOON. THE CT SHOWED THAT THE VALVE AREA OF THE RCC WAS LESS THAN HALF OF THAT OF THE LCC. ALSO, IN THE VALVE AREA OF THE RCC, THERE WERE PARTS WITH CONTRAST MEDIA AND PARTS WITHOUT, SHOWING A BLACK-AND-WHITE CONTRAST WHICH IS NOT SEEN IN A REGULAR CT SCAN (IT LOOKED LIKE A POLKA-DOT PATTERN.) - INDICATING THAT COAPTATION WAS POOR. THE LEAFLET MOVEMENT WAS THOUGHT TO DUE TO POOR EXPANSION. ALTHOUGH THE LVOT (LEFT VENTRICULAR OUTFLOW TRACT) WAS ELLIPTICAL IN PRE-PROCEDURAL ANALYSIS, THE VALVE EXPANDED TO A PERFECT CIRCLE, WITH NO STENT DEVIATION OBSERVED IN THIS AREA. THE ECHO FOLLOW-UP ON (B)(6) 2024 SHOWED AORTIC REGURGITATION REMAINED MILD. PATIENT WAS HOSPITALIZED FOR MONITORING. ON (B)(6) 2024, THE REGURGITATION HAD WORSENED TO SEVERE. DUE TO HEART FAILURE, PATIENT WAS GIVEN DIURETICS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1149061 | NAVITOR VISION | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED | NPT | ABBOTT MEDICAL | 10313927 | 05415067045782 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 93 YR | Female | Hospitalization| R | SMALL FLEXNAV DELIVERY SYSTEM |